How Universities Became the Engine of the Biotech Industry
April 21, 2026
Dana–Farber Cancer Institute
05Institution Overview
#5In Institutes & Centers
#6In Research Capabilities
#18In Entrepreneurial Readiness
#3In Market Translation
Index 20 Institutes & Centers
Boston, MA
Dana-Farber Cancer Institute ranks among the top institutions in the Cure Innovation Index, standing fifth among America's leading independent research institutes. The Boston-based organization combines world-class cancer research with a robust commercialization infrastructure, including an active incubator and entrepreneur-in-residence program. With 21 National Academy members and a Howard Hughes Medical Institute affiliation, Dana-Farber maintains exceptional research capacity while actively translating discoveries into clinical practice and commercial applications. Its physicians serve as principal investigators in leading clinical trials, bridging the laboratory and bedside across the innovation spectrum.
Ranking Metrics
Research Capabilities
Dana–Farber Cancer Institute ranked above average for Research Capabilities, a measure of the foundational infrastructure and resources that enable an institution to conduct high-quality, innovative science. Out of the factors in this category, Dana–Farber Cancer Institute fared best in Funding Support.
Learn MoreEntrepreneurial Readiness
Dana–Farber Cancer Institute ranked below average for Entrepreneurial Readiness, a measure of whether the institution has built a supportive ecosystem for entrepreneurship and whether faculty are engaged in and incentivized toward commercial activity. Out of the factors in this category, Dana–Farber Cancer Institute fared best in Faculty Engagement.
Learn MoreMarket Translation
Dana–Farber Cancer Institute ranked above average for Market Translation, a measure of how effectively a research institution moves scientific discovery out of the lab and into real-world clinical and commercial applications. Out of the factors in this category, Dana–Farber Cancer Institute fared best in Health Impact.
Learn More
Cure Innovation Index Methodology
From a pool of more than 6,000 institutions, the top 303 were ranked using two dozen indicators — from scientific foundation and lab infrastructure to patents, products, and partnerships — drawn from more than a dozen federal and commercial databases, an original audit of all institutions, and surveys of more than 3,300+ scientists, industry leaders, and biomedical experts.
Insights From the Cure Innovation Index
Explore by Category
Innovation isn't a single moment — it's an entire ecosystem. The Index evaluates institutions across two dozen indicators, grouped in three core domains that reveal the full picture of what it takes to turn groundbreaking science into real-world impact.
